🔎 Trials Near Me

Home › Mieloma multiplico smoldering › New York

Studi clinici su Mieloma multiplico smoldering nello stato di New York

8 studi su Mieloma multiplico smoldering cercano partecipanti presso sedi nello stato di New York.

Città nello stato di New York

Testo ufficiale dello studio (inglese)

A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07393282

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

  • Hematology Oncology Associates of CNY at Camillus, Camillus
  • Hematology Oncology Associates of Central New York-East Syracuse, East Syracuse
  • Mount Sinai Chelsea, New York
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 19 ago 2026 · NCT03937635

A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

  • NYU Langone Health Perlmutter Cancer Center, New York
  • Stony Brook University Hospital, Stony Brook
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT06140524

A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

  • Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 apr 2026 · NCT05640843

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

  • Roswell Park Cancer Institute, Buffalo
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 dic 2025 · NCT05312255

A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)

  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 13 nov 2025 · NCT06055894

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
In reclutamentoStudio osservazionale
Età 40 e oltre · Tutti i sessi · Aggiornato il 6 ago 2025 · NCT06365060

Selinexor for the Treatment of Intermediate and High-Risk Smoldering Multiple Myeloma

  • University of Rochester, Rochester
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 feb 2025 · NCT05597345

Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.